Evotec SE (EVO) Other Non Operating Income (2009 - 2025)
Evotec SE (EVO) reported Other Non Operating Income of $1393.5 for Q3 2025, up 111.24% on a YoY basis from $659.69 in Q3 2024, and up 111.24% sequentially from -$12398.9 in Q3 2024.
Evotec SE (EVO) Other Non Operating Income (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 9 years of Other Non Operating Income data on file, last reported at $1393.5 in Q3 2025.
- For the quarter ending Q3 2025, Other Non Operating Income rose 111.24% year-over-year to $1393.5; the trailing twelve-month figure through Sep 2025 stood at -$19855.5 (down 119.7% YoY), and the FY2022 full-year result was $145895.4, up 51.83% from the prior year.
- Other Non Operating Income rose to $1393.5 in Q3 2025, from -$12398.9 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $122025.7 in Q4 2022 to a low of -$13641.0 in Q2 2023.
- A 5-year average of $18531.3 and a median of $898.22 in 2025 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income soared 179867.64% in 2022 and slumped 358.8% in 2024, its largest moves.
- Tracing EVO's Other Non Operating Income over 5 years: stood at $96003.2 in 2021, then increased by 27.11% to $122025.7 in 2022, then tumbled by 96.07% to $4790.9 in 2023, then tumbled by 358.8% to -$12398.9 in 2024, then jumped by 111.24% to $1393.5 in 2025.
- Business Quant data shows EVO's Other Non Operating Income at $1393.5 in Q3 2025, -$12398.9 in Q3 2024, and $4790.9 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,393.51 |
| Sep 30, 2024 | -12,398.90 |
| Sep 30, 2023 | 4,790.89 |
| Jun 30, 2023 | -13,640.96 |
| Dec 31, 2022 | 122,025.67 |
| Sep 30, 2022 | 2,032.68 |
| Jun 30, 2022 | 21,672.99 |
| Mar 31, 2022 | 402.92 |
| Dec 31, 2021 | 96,003.19 |
| Sep 30, 2021 | 69.58 |
| Jun 30, 2021 | 12.04 |
| Mar 31, 2021 | 12.06 |
| Dec 31, 2020 | -8.26 Mn |
| Sep 30, 2020 | -3,154.98 |
| Dec 31, 2019 | 1.35 Mn |
| Sep 30, 2010 | -113.63 |
| Jun 30, 2010 | 274.09 |
| Mar 31, 2010 | 83.08 |
| Dec 31, 2009 | 493,112.57 |
| Jun 30, 2009 | 64.00 |